Printer Friendly
The Free Library
14,678,647 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bruker AXS Announces the VANTEC-2000 - a Novel 2D Detector for Demanding X-Ray Diffraction Applications in Materials Research.


ORLANDO, Fla. -- At Pittcon 2005, Bruker AXS, an operating company operating company

A business that engages in transactions with outsiders.
 of Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use.  (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BRKR BRKR Breaker ), today announces the VANTEC(TM)-2000, a cutting-edge high-performance two-dimensional (2D) X-ray detector based on patented innovative MikroGap(TM) technology, for demanding X-ray diffraction (XRD XRD X-Ray Diffraction
XRD Crossroad
XRD X-Ray Diode
) applications in advanced materials research.

The VANTEC-2000 is based on the same technology as Bruker AXS' one-dimensional VANTEC-1 detector, which was introduced in 2003. Because of its high speed measurement capability with no compromise in angular resolution, the VANTEC-1 has become hugely successful with more than 80 customer installations worldwide within the last twelve months.

With the introduction of the VANTEC-2000, Bruker AXS is advancing the limits of X-ray diffraction technology for research applications in materials science one step further. The VANTEC-2000 features the proprietary MikroGap(TM) technology to achieve an impressive 14 x 14 cm(2) active area, with outstanding spatial resolution of 70 (mu)m and an unprecedented dynamic range of 10(8). The VANTEC-2000 combines all the advantages of gaseous detectors with the benefits of solid state detectors. Its unique technology allows the realization of almost completely noise-free detectors which are unique in terms of robustness, resolution, sensitivity and dynamic range.

In addition, with its real-time data display and true photon counting capabilities, the VANTEC-2000 is the ideal detector for non-destructive nanotechnology investigations by X-ray diffraction. It improves data quality in applications such as small-angle X-ray scattering Small-angle X-ray scattering (SAXS) is a small-angle scattering (SAS) technique where the elastic scattering of X-rays (wavelength 0.1 ... 0.2 nm) by a sample which has inhomogeneities in the nm-range, is recorded at very low angles (typically 0.1 - 10°).  (SAXS SAXS Small Angle X-Ray Scattering ), thin film investigations and micro-XRD analysis, i.e. in very demanding applications where the scattered X-ray signal is weak, a high dynamic range needs to be covered and highest resolution is crucial.

Dr. Frank Burgaezy, Global XRD Business Manager for Bruker AXS, commented: "We are proud to introduce our new VANTEC-2000 detector to the materials research community. This novel detector will push the forefront of research in materials science and will significantly improve throughput and reliability for industrial X-ray diffraction applications. The VANTEC-2000 is simply redefining the limits of high-performance XRD."

Pittcon 2005, the 56th Pittsburgh Conference and Exposition on Analytical Chemistry and Applied Spectroscopy, is being held from February 27 through March 4 in the Orange County Convention Center The Orange County Convention Center (OCCC) is the primary public convention center in Central Florida. The large complex is located on International Drive, a major tourist area in Orlando, Florida. . The product introduced here will be exhibited at the Bruker booth #3176.

ABOUT BRUKER BIOSCIENCES

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com.

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending and government funding policies, FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2003, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 28, 2005
Words:621
Previous Article:ValueClick Announces Participation in Upcoming Investor Conferences.
Next Article:Bruker Daltonics Introduces Affordable microflex LT MALDI-TOF for Routine Peptide and Protein Analysis.



Related Articles
Bruker AXS Launches New SuperSpeedSolutions-TM- for Materials Research and Nanostructure Applications.
Bruker AXS Wins Frost & Sullivan Market Leadership Award in X-ray Diffraction.
Bruker AXS Launches its New XRD2 Solutions for Materials Research.
Bruker AXS Wins Prestigious R&D 100 Award For Innovative VANTEC(TM)-2000 X-ray Detector Used in Materials Science Research.
Bruker AXS Launches Affordable New LynxEye(TM) 1D-Detector for Fast X-Ray Diffraction Measurements in Materials Research and Process Analysis.
Bruker AXS Announces AUTOSTRUCTURE(TM) Software for Automated X-Ray Structure Determination.
Bruker AXS Announces SMART BREEZE(TM), an Affordable and Exceptionally Easy-to-Use X-Ray Crystallography System for Automated Molecular 3D Structure...
Bruker AXS Announces Agreement to Acquire X-Ray Microanalysis Company Roentec AG.
Bruker AXS and Bruker Optics Introduce D8 SCREENLAB(TM), a Combined XRD and Raman High-Throughput Screening System for Advanced Materials Research.
Bruker AXS Wins Prestigious R&D 100 Award For Novel XFlash QUAD Detector for X-ray Microanalysis on Electron Microscopes; Bruker AXS to Demonstrate...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles